Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Increased monocyte activation as a source of chronic inflammation and driver of biological aging in older adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. ABO blood types and sepsis mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. TAM Receptor Inhibition-Implications for Cancer and the Immune System

    Publikation: Bidrag til tidsskriftReviewpeer review

Vis graf over relationer

Survivin is overexpressed in several malignancies and in tumor-associated endothelium making it an attractive target for therapeutic cytotoxic T-cell responses. Thus, it would be important to test this notion in preclinical models. Consequently, we screened the murine survivin sequence for potential binding K(b)-restricted octamer peptide epitopes. Two epitopes, which bind strongly to K(b), were selected to test their immunogenicity in vivo. Spleen cells from mice vaccinated by intradermal injection of mature DC pulsed with these peptides displayed reactivity to the respective epitopes. The natural processing and presentation of these epitopes by tumor cells was evident by the killing of murine melanoma cells by vaccination-induced T cells. Subcutaneous challenge with syngeneic melanoma demonstrated the protective immunity of this vaccination. Notably, analysis of the vessel density in subcutaneous tumors revealed that survivin-specific vaccination significantly reduced the number of intratumoral vessels. In summary, we demonstrated the immunogenicity of two K(b)-restricted peptide epitopes derived from the murine survivin protein; moreover, survivin-specific vaccination not only resulted in a reduction of tumor cells but also the tumor supplying blood vessels. The presented preclinical model for survivin-directed vaccination may serve as a valuable tool to improve already running clinical trials in a syngeneic tumor model.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Immunology
Vol/bind39
Udgave nummer5
Sider (fra-til)1419-24
Antal sider6
ISSN0014-2980
DOI
StatusUdgivet - maj 2009

ID: 52222421